[Source: The Arizona Republic] – A study of an experimental scorpion antivenin administered at hospitals statewide shows encouraging results, but the timeline for government approval remains unknown.
The antivenin, Anascorp, is the subject of a study led by the University of Arizona to test the medication’s safety and effectiveness.
For more information: Scorpion antivenin tested in University of Arizona study